Navigation Links
3SBio Inc. Announces Unaudited Second Quarter Results
Date:8/17/2010

ited financial statements and related notes are to be included in our annual report on Form 20-F for the year ending December 31, 2010. Adjustments and modifications to the financial statements may be identified during the course of the audit work, which could result in significant differences from this preliminary unaudited financial information.

Currency Convenience Translation

For the convenience of readers, certain RMB amounts have been translated into US dollars at the rate of RMB6.7815 to US$1.00, the noon buying rate for US dollars in effect on June 30, 2010 for cable transfers of RMB per US dollar as certified for customs purposes by the Federal Reserve Bank of New York. A rate of 6.8302 was used for comparative purposes as of June 30, 2009.

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at http://www.3sbio.com .

Safe Harbor Statement

Certain statements in the disclosures of 3SBio, Inc. (the "Company" or "3SBio") for the second quarter of fiscal 2010 ("Disclosures") that are not purely historical in nature may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. The Disclosures include the press release, the conference call and any accompanying materials, and any other information issued, released or publicized by the Company with respect to fiscal 2010 and the second quarter.

These forward-looking statements address activities, events, conditions, or developments that we currently expect or anticipate may occur in the future, and include, but may not be limited to, discussions and statements regarding revenue guidance; product development; impact of the government policies and regulation; regulatory approval pro
'/>"/>

SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. 3SBio Inc. Announces Second Quarter 2008 Results
2. 3SBio Inc. to Hold Annual General Meeting
3. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4. 3SBio Inc. Announces Results of Annual General Meeting
5. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
6. 3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO
7. 3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 2008
8. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results
9. 3SBio Inc. Files for SFDA Approval of NuLeusin
10. 3SBio Inc. Announces Third Quarter 2008 Results
11. 3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 On June 11, 2013 ... released a final decision memorandum concluding that FDG Position ... management of anti-tumor strategy, and the agency ended ... Oncological PET Registry (NOPR) was developed jointly by the ... under the Coverage with Evidence Development (CED) program to ...
(Date:6/18/2013)... 2013 Kitware , a leading ... new Fast-Track award from the U.S. Department of Energy ... for the nuclear power industry. , Construction of nuclear ... 30 years, but the United States’ nuclear power industry ... power plant utilization through improved refueling, maintenance, and safety ...
(Date:6/17/2013)... , June 17, 2013  KaloBios Pharmaceuticals, Inc. ... of Donald R. Joseph as Chief Legal ... of biopharmaceutical industry experience and has worked in both ... health non-profit organizations. (Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO ... track record as a general counsel and senior executive ...
(Date:6/17/2013)... June 17, 2013 The Defense Threat ... Technical Review at the Waterford in Springfield, Virginia on ... grant awardees will present technical details on their counter ... cover a broad range of counter WMD areas including: ... and Network Science; (3) Science for Protection; (4) Science ...
Breaking Biology Technology:WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 3Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research 2KaloBios Appoints Donald R. Joseph as Chief Legal Officer 2KaloBios Appoints Donald R. Joseph as Chief Legal Officer 3KaloBios Appoints Donald R. Joseph as Chief Legal Officer 4Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review 2
... KOSN ) will announce its first quarter 2008 ... The announcement of Kosan,s first quarter 2008 financial ... webcast on May 1, 2008 at 1:30,p.m. Pacific / ... by dialing 888.680.0878 (US) or 617.213.4855 (international), access,code 63268386. ...
... SAN FRANCISCO, Calif., April 24 ,Exelixis, Inc. (Nasdaq: ... and chief executive officer of Exelixis, will present at ... ET/12:40,p.m. PT on Wednesday, April 30, 2008. Dr. Scangos ... strategy., The presentation will be webcast and may ...
... HOLX ), a diversified medical technologies company ... dedicated to,serving the healthcare needs of women, today ... operating results on Thursday, May 1, 2008 at,8:00 ... will host,a conference call on Thursday, May 1, ...
Cached Biology Technology:Kosan Announces May 1, 2008 Conference Call and Webcast of First Quarter 2008 Financial Results 2Hologic, Inc. to Release Second Quarter Fiscal 2008 Operating Results Thursday, May 1st Before Market Opens 2
(Date:6/18/2013)... Faculty of Medicine have discovered a mechanism that is ... a component of blood typically associated with clotting, were ... detection, seal it off from the rest of the ... Immunology this week, provide the science community with ... has known that platelets do participate in immunity, but ...
(Date:6/18/2013)... United Kingdom, the Energy Department,s National Renewable Energy ... recently published a paper describing a novel cellulose-degrading ... quadripunctata , commonly known as the gribble. ... a relatively unique ability to produce their own ... down the biomass they eat. New biomass-degrading enzymes ...
(Date:6/18/2013)... A UT Arlington environmental engineer has been awarded ... District to ensure water quality and flow in ... Project. , Andrew Kruzic, UT Arlington associate professor ... and locations to add monochloramine to the water ... the new pump stations and pipelines. Adding monochloramine ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2Novel enzyme from tiny gribble could prove a boon for biofuels research 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2
... Disease Control and Prevention estimates that almost 18% of ... our growing obesity "epidemic" is driven by both inadequate ... extraordinarily difficult. One area that has caught the attention ... video game playing parallel obesity rates on a population ...
... the smoking ban in restaurants, bars and nightclubs, customers ... odors and the smell of old beer, that used ... looking at how the introduction of pleasant ambient scents ... According to Dr. Hendrik Schifferstein from Delft University of ...
... May 17, 2010 Country roadways can be hazardous for ... with moose, elk and caribou in North America and Europe ... the salt pools that collect following pavement deicing. ... with males weighing up to 720 kilograms, their salt cravings ...
Cached Biology News:Rigorous study confirms video game playing increases food intake in teens 2Clubbers can smell a good nightspot 2Of moose and men 2
... Provides a fast and easy method ... mitochondrial fraction from mammalian tissues. Most ... inner and outer membranes. The kit ... studies and proteome profiling. Also included ...
... and other fluid sources for 4 vessels ... of each individual pump is controlled electronically. ... exactly maintained. ,High-precision controlled peristaltic pumps ... which allows flow rates between 0.01 to ...
... The SearchLight® IR Mouse Cytokine Array ... assay) for the quantitative measurement of 12 ... plasma and culture supernatants. Each well of ... that capture specific cytokines in standards and ...
... cassette is designed to allow ampicillin selection ... gb2 driving the gene for ampicillin resistance ... Em7 promoter. It mediates higher transcription efficiency ... synthetic polyadenylation signal terminates the ampicillin expression. ...
Biology Products: